|
|
|
|
|
| (11) | Liudijimo numeris | |
| (68) | Patento numeris | 3678649 |
| (21) | Paraiškos papildomos apsaugos liudijimui gauti numeris | PA 2025 507 |
| (22) | Paraiškos papildomos apsaugos liudijimui gauti padavimo data | 2025-02-11 |
| (41) | Paraiškos papildomos apsaugos liudijimui gauti paskelbimo data | 2025-02-25 |
| Liudijimo paskelbimo data | ||
| (24) | Liudijimo įsigaliojimo data |
| (71) |
Aegis Therapeutics, LLC ,
3430 Carmel Mountain Road, Suite 300, San Diego CA 92121,
US
ARS Pharmaceuticals Operations, Inc. , 11682 El Camino Real, Suite 120, San Diego, CA 92130, US |
| (73) |
Aegis Therapeutics, LLC ,
3430 Carmel Mountain Road, Suite 300, San Diego CA 92121,
US
ARS Pharmaceuticals Operations, Inc. , 11682 El Camino Real, Suite 120, San Diego, CA 92130, US |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (93) | EU/1/24/1846, 2024-08-22 |
| (95) | Visų formų epinefrino ir dodecilmaltozido derinys saugomas pagrindinio patento |
| PA paraiška paskelbta |